author-photo

Youcef M. Rustum

Roswell Park Cancer Institute

290

Papers

9083

Citations

Citation Trend

Filter By

Papers (290) Sort By

JournalConferenceOthers

Phase I with expansion clinical trial of seleno-l-methionine (SLM) in combination with axitinib in patients with relapsed clear cell renal cell carcinoma (ccRCC): Bench to bedside.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PD39-02 RESULTS OF PHASE 1 CLINICAL TRIAL OF HIGH DOSES OF SELENO-L-METHIONINE (SLM) IN SEQUENTIAL COMBINATION WITH AXITINIB IN PREVIOUSLY TREATED AND RELAPSED CLEAR CELL RENAL CARCINOMA (CCRCC) PATIENTS

2020 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (1)
Preliminary results of phase I clinical trial of high doses of seleno-L-methionine (SLM) in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases

2019
- Youcef M. Rustum
Show All
- Source
- Cite
- Save
Citations (0)
Phase1 clinical trial of high doses of Seleno-L-methionine (SLM), in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development *

2018 Oncotarget
Show All
- Source
- Cite
- Save
Citations (16)
Current Landscape and the Potential Role of HIF and Selenium in Clear Cell Renal Cell Carcinoma Treatment

2018
Show All
- Source
- Cite
- Save
Citations (0)
Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment

2018 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (14)
Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma—Bench-to-Bedside Therapy

2018 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (8)
Enrico Mihich, MD: In Memoriam (1928–2016)

2017 Cancer Research
- Margaret Foti
- Youcef M. Rustum
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号